The M&A-focused Betaville blog sent an alert to its subscribers related to a rumor regarding Soleno Therapeutics (SLNO), contacts tell The Fly. Soleno shares are up 58c, or 1% to $82.00 in morning trading.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SLNO:
- DoorDash, AMD upgraded: Wall Street’s top analyst calls
- Soleno Therapeutics initiated with a Buy at TD Cowen
- Soleno Therapeutics Holds Annual Stockholders Meeting
- Soleno Therapeutics seeking regulatory approval in treatment of PWS
- Soleno Therapeutics presents Vykat XR data at Pediatric Endocrine Society